NERV vs CTMX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 24, 2026
NERV
CTMX
Investment Advisor Scores
CTMX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | NERV | CTMX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 11.2108 | 14.2045 | NERV |
| PEG Ratio | 0 | -1.8 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 0.0% | -92.4% | NERV |
| Earnings Growth | 0.0% | 60.6% | CTMX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 32.6/100 | 47.2/100 | CTMX |
| Profit Margin | 0.0% | 0.0% | Tie |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | EXTENDED | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
NERV
NeutralMixed signals - no dominant trend phase, RSI 59
CTMX
DistributionPrice near a flattening SMA50 (slope -0.9%) with fading momentum, RSI 48
Fundamentals Snapshot
| Metric | NERV | CTMX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -11.5 | -7.0 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | -0.9% |
| Gross Margin | — | 1.0% |
| Operating Margin | 0.0% | -16.8% |
| EPS | -36.12 | -0.57 |
| Dividend Yield | — | — |